{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:48:28Z","timestamp":1776984508656,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.urolonc.2023.08.014","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:07:59Z","timestamp":1695877679000},"page":"22.e23-22.e31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9712-2685","authenticated-orcid":false,"given":"Stefano","family":"Tappero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia Luca","family":"Piccinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Cano Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reha-Baris","family":"Incesu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Morra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Scheipner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Baudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Dell'Oglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottavio","family":"de Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix K.H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Ahyai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Carmignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazareno","family":"Suardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Borghesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Terrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2023.08.014_bib0001","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/annonc\/mdf257","article-title":"Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Fran\u00e7ais d'Immunoth\u00e9rapie","volume":"13","author":"N\u00e9grier","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0002","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0090-4295(02)02163-5","article-title":"Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma","volume":"61","author":"Han","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0003","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1158\/1078-0432.CCR-11-0553","article-title":"Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group","volume":"17","author":"Manola","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0004","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.euf.2017.12.007","article-title":"The development of brain metastases in patients with renal cell carcinoma: epidemiologic trends, survival, and clinical risk factors using a population-based cohort","volume":"5","author":"Sun","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0005","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/iju.12004","article-title":"Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy","volume":"20","author":"Capitanio","year":"2013","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0006","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2217\/fon-2017-0175","article-title":"Clinical correlates and prognostic value of different metastatic sites in metastatic renal cell carcinoma","volume":"13","author":"Abdel-Rahman","year":"2017","journal-title":"Future Oncol"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0007","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","volume":"23","author":"Bianchi","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0008","doi-asserted-by":"crossref","first-page":"661.e7","DOI":"10.1016\/j.urolonc.2017.06.060","article-title":"Metastatic renal cell carcinoma: patterns and predictors of metastases\u2014a contemporary population-based series","volume":"35","author":"Chandrasekar","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.21869","article-title":"Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival","volume":"4","author":"Dudani","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.eururo.2013.08.012","article-title":"Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy","volume":"65","author":"McKay","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0011","unstructured":"Howlader N, Noone A, Krapcho M, et al: Cancer statistics review, 1975-2018 - SEER statistics. Available at: https:\/\/seer.cancer.gov\/csr\/1975_2018\/, Accessed April 13, 2022."},{"key":"10.1016\/j.urolonc.2023.08.014_bib0012","unstructured":"Anon: R: the R project for statistical computing. Available at: https:\/\/www.r-project.org\/, Accessed April 14, 2022."},{"key":"10.1016\/j.urolonc.2023.08.014_bib0013","doi-asserted-by":"crossref","first-page":"17822","DOI":"10.1038\/s41598-021-97365-6","article-title":"The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database","volume":"11","author":"Wei","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0014","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clgc.2022.08.010","article-title":"Mortality according to treatment in metastatic collecting duct renal cell carcinoma","volume":"21","author":"Panunzio","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0015","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.euf.2020.04.009","article-title":"Association between systemic therapy and\/or cytoreductive nephrectomy and survival in contemporary metastatic non-clear cell renal cell carcinoma patients","volume":"7","author":"Luzzago","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0016","doi-asserted-by":"crossref","first-page":"493.e9","DOI":"10.1016\/j.urolonc.2022.06.022","article-title":"Other-cause mortality and access to care in metastatic renal cell carcinoma according to race\/ethnicity","volume":"40","author":"Sorce","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0017","first-page":"111","article-title":"Prognostic impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma: data from a large population-based database","volume":"19","author":"Alnimer","year":"2021","journal-title":"Urol J"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0018","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2002.20.1.289","article-title":"Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma","volume":"20","author":"Motzer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2023.08.014_bib0019","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study","volume":"27","author":"Heng","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923002880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923002880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:27:49Z","timestamp":1761042469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143923002880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1078143923002880"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.08.014","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}